Bladder cancer predisposition: A multigenic approach to DNA-repair and cell-cycle-control genes

American Journal of Human Genetics

Volumn 78, Issue 3, 2006, Pages 464-479

  Wu, Xifeng ^a   Gu, Jian ^a   Grossman, H Barton ^a   Amos, Christopher I ^a   Etzel, Carol ^a   Huang, Maosheng ^a   Zhang, Qing ^a   Millikan, Randal E ^a   Lerner, Seth ^b   Dinney, Colin P ^a   Spitz, Margaret R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; ASPARTIC ACID; BLEOMYCIN; DIHYDROXYBENZO[A]PYRENE OXIDE; LYSINE; PROTEIN P53; RAG1 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CELL CYCLE REGULATION; CHROMATID; CHROMOSOME BREAKAGE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; EXCISION REPAIR; FEMALE; GENE; GENE DOSAGE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HIGH RISK POPULATION; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MUTAGEN TESTING; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; VALIDATION PROCESS; XPD GENE;

EID: 33344464252     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/500848     Document Type: Article

References (30)

1. Benhamou S, Sarasin A (2005) ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 161:1-14
2. Berwick M, Vineis P (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92:874-897
3. Cheng TC, Chen ST, Huang CS, Fu YP, Yu JC, Cheng CW, Wu PE, Shen CY (2005) Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113:345-353
4. Christmann M, Tomicic MT, Roos WP, Kaina B (2003) Mechanisms of human DNA repair: an update. Toxicology 193:3-34
5. Elledge SJ (1996) Cell cycle checkpoints: preventing an identity crisis. Science 274:1664-1672
6. Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11:1513-1530
7. Gu J, Zhao H, Dinney CP, Zhu Y, Leibovici D, Bermejo CE, Grossman HB, Wu X (2005) Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res 11:1408-1415
8. Han J, Colditz GA, Samson LD, Hunter DJ (2004) Polymorphisms in DNA double-strand break repair genes and skin cancer risk. Cancer Res 64:3009-3013
9. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
10. Home BD, Anderson JL, Carlquist JF, Muhlestein JB, Renlund DG, Bair TL, Pearson RR, Camp NJ (2005) Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints. Ann Hum Genet 69:176-186
11. Hsu TC, Johnston DA, Cherry LM, Ramkissoon D, Schantz SP, Jessup JM, Winn RJ, Shirley L, Furlong C (1989) Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 43:403-409
12. Hu Z, Wei Q, Wang X, Shen H (2004) DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Lung Cancer 46:1-10
13. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29:306-309
14. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10-30
15. Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, Day NE, Easton DF, Ponder BA, Pharoah PD, Dunning A (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11:1399-1407
16. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177-182
17. Matullo G, Peluso M, Polidoro S, Guarrera S, Munnia A, Krogh V, Masala G, Berrino F, Panico S, Tumino R, Vineis P, Palli D (2003) Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev 12:674-677
18. Mohrenweiser HW, Wilson DM 3rd, Jones IM (2003) Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res 526:93-125
19. Neumann AS, Sturgis EM, Wei Q (2005) Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol Carcinog 42:65-92
20. Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, Bartsch H, Schmezer P (2004) Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25:2433-2441
21. Schabath MB, Spitz MR, Grossman, HB, Zhang K, Dinney CP, Zheng PJ, Wu X (2003) Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst 95:540-547
22. Shields PG, Harris CC (2000) Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18:2309-2315
23. Spitz MR, Wei Q, Dong Q, Amos CI, Wu X (2003) Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 12:689-698
24. Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, Guo Z, Lei L, Mohrenweiser H, Wei Q (2001) Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 61:1354-1357
25. Stern MC, Johnson LR, Bell DA, Taylor JA (2002) XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11:1004-1011
26. Wu X, Gu J, Amos CI, Jiang H, Hong WK, Spitz MR (1998a) A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung cancer cases and controls. Cancer 83:1118-1127
27. Wu X, Gu J, Hong WK, Lee JJ, Amos CI, Jiang H, Winn RJ, Fu KK, Cooper J, Spitz MR (1998e) Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst 90:1393-1399
28. Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK, Kadlubar FF, Spitz MR (2002) p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst 94:681-690
29. Wu X, Zhao H, Suk R, Christiani DC (2004) Genetic susceptibility to tobacco-related cancer. Oncogene 23:6500-6523
30. Wu X, Zhao H, Wei Q, Amos CI, Zhang K, Guo Z, Qiao Y, Hong WK, Spitz MR (2003) XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis 24:505-509